EquityZen Growth Technology Fund LLC - Series 107
Raised
$196K
Investors
11
Min Invest
$10,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 107 is a Delaware-organized pooled investment fund filed by EquityZen Advisors LLC on 2017-09-05, raising $196K from 11 investors with a $10K minimum investment under Rule 506(b) and Section 3(c)(1). This entity is part of the EquityZen platform, which operates nearly 1,900 pre-IPO investment vehicles focused on secondary shares in private technology companies.
This pre-IPO vehicle uses the standard 506(b)/3(c)(1) exemption structure typical of small private fund offerings, with a $10K minimum investment positioning it at the accessible end of the alternative investment spectrum. The sub-$200K raise and 11-investor base reflect the single-deal SPV model common to secondary marketplaces enabling retail-adjacent access to pre-IPO equity.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Erin Rosenthal
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Shiraram Bhashyam
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
